Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 7
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort ascending | Purpose |
---|---|---|---|---|---|---|
Implementation of measures to reduce vasovagal reactions: Donor participation and results | Goldman M, Uzicanin S, Marquis-Boyle L, O'Brien SF | 2021 | Transfusion | View Implementation of measures to reduce vasovagal reactions: Donor participation and results | Health care providers | Clinical research |
Blood Donation Testing and the Safety of the Blood Supply | Goldman M, Drews SJ | 2022 | Practical Transfusion Medicine | View Blood Donation Testing and the Safety of the Blood Supply | Health care providers | Benchmarking and standard setting |
FAQ: Canadian Blood Services platelet bacterial screening | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View FAQ: Canadian Blood Services platelet bacterial screening | Health care providers | Benchmarking and standard setting |
Chapitre 10. Les réactions transfusionnelles | Laureano M, Khandelwal A, Yan M | 2022 | Guide de la pratique transfusionnelle | View Chapitre 10. Les réactions transfusionnelles | Health care providers | Benchmarking and standard setting |
A Mother and Newborn with Brown Blood | Estey MP, Clarke G, Sia W, Toor E, Higgins TN | 2015 | Clin Chem | View A Mother and Newborn with Brown Blood | Health care providers | Clinical research |
Acquired peanut hypersensitivity following platelet transfusion | Ponnampalam A, Growe G, Loftus P, Chipperfield K, Bigham M | 2014 | Transfus Med | View Acquired peanut hypersensitivity following platelet transfusion | Health care providers | Clinical research |
Bleeding complications in immune thrombocytopenia | Arnold DM | 2015 | Hematology Am Soc Hematol Educ Program | View Bleeding complications in immune thrombocytopenia | Health care providers | Clinical research |
CMV seronegative, irradiated and washed blood components | Prokopchuk-Gauk O, Solh Z | 2017 | Clinical Guide to Transfusion | View CMV seronegative, irradiated and washed blood components | Health care providers | Benchmarking and standard setting |
Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative - UK NEQAS(H) International Exercise | Lozano M, Mahon A, van der Meer PF, Stanworth S, Cid J, Devine D, Fung MK, de la Salle B, Heddle NM, on behalf of Biomedical Excellence for Safer Transfusion Collaborative | 2014 | Vox Sang | View Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative - UK NEQAS(H) International Exercise | Health care providers | Benchmarking and standard setting |
Expert approaches to common bleeding and thrombotic problems-part I | Hayward CP, Webert KE | 2012 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems-part I | Health care providers | Other |
Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | McEneny-King A, Chelle P, Henrard S, Hermans C, Iorio A, Edginton AN | 2017 | Pharmaceutics | View Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | Health care providers | Clinical research |
Peanut and fish allergy due to platelet transfusion in a child | Ching JC, Lau W, Hannach B, Upton JE | 2015 | CMAJ | View Peanut and fish allergy due to platelet transfusion in a child | Health care providers | Clinical research |
Platelet product quality remains high after seven days of storage | Serrano K, Schubert P, Devine D | 2017 | Blood.ca website | View Platelet product quality remains high after seven days of storage | Health care providers | New or improved product or process |
Pre-transfusion testing | Lane D | 2017 | Clinical Guide to Transfusion | View Pre-transfusion testing | Health care providers | Benchmarking and standard setting |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Shehata N, Chassé M, Colas JA, Murphy M, Forster AJ, Malinowski AK, Ducharme R, Fergusson DA, Tinmouth A, Wilson K | 2017 | Transfusion | View Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Health care providers | Clinical research |
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Poudel DR, Ghimire S, Dhital R, Forman DA, Warkentin TE | 2017 | Platelets | View Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Health care providers | Clinical research |
The Stem Cell Club: a model for unrelated stem cell donor recruitment | Fingrut W, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang YG, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H | 2017 | Transfusion | View The Stem Cell Club: a model for unrelated stem cell donor recruitment | Health care providers | New or improved product or process |
Transfusion reactions: prevention, diagnosis, and treatment | Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A | 2016 | Lancet | View Transfusion reactions: prevention, diagnosis, and treatment | Health care providers | Clinical research |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Diego System: Anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Wra | Health care providers | Benchmarking and standard setting |
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S | 2019 | JAMA Intern Med | View Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Health care providers | Benchmarking and standard setting |
Perinatal issues in transfusion practice | Lieberman L, Clarke G, Svensson A | 2020 | AABB Technical Manual, 20th Edition | Health care providers | Benchmarking and standard setting | |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Stewart T | 2021 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Health care providers | Benchmarking and standard setting |
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study | Paes B, Chan AKC, Shaik M, Patel D, Bhatt MD | 2022 | Blood Coagul Fibrinolysis | View Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study | Health care providers | Clinical research |
Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Laureano M, Mithoowani S, Tseng E, Zeller M | 2021 | Adv Med Educ Pract | View Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Health care providers | Benchmarking and standard setting |
Chapter 16: Preoperative autologous donation | Foster T, Yan M | 2021 | Clinical Guide to Transfusion | View Chapter 16: Preoperative autologous donation | Health care providers | Benchmarking and standard setting |
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Lieberman L, Lopriore E, Baker JM, Bercovitz RS, Christensen RD, Crighton G, Delaney M, Goel R, Hendrickson JE, Keir A, Landry D, La Rocca U, Lemyre B, Maier RF, Muniz-Diaz E, Nahirniak S, New HV, Pavenski K, Dos Santos MCP, Ramsey G, Shehata N, International Collaboration for Transfusion Medicine Guidelines | 2022 | Brit J Haem | View International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Health care providers | Benchmarking and standard setting |
A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins | Kelton JG, Warkentin TE, Moore JC, Arnold DM, Nazi I, Arepally GM, Roach JM, Fier I | 2012 | J Thromb Haemost | View A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins | Health care providers | Clinical research |
Autoimmune heparin-induced thrombocytopenia | Greinacher A, Selleng K, Warkentin TE | 2017 | J Thromb Haemost | View Autoimmune heparin-induced thrombocytopenia | Health care providers | Clinical research |
Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C | 2012 | Transfusion | View Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Health care providers | New or improved product or process |
How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey | Patriquin CJ, Clark WF, Pavenski K, Arnold DM, Rock G, Foley SR, for the Canadian Apheresis Group | 2016 | J Clin Apher | View How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey | Health care providers | Clinical research |
Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Patel SN, Gubbay JB, Bastien N, Booth T, Charest H, Chernesky M, Couillard M, Drews S, Garceau R, Gubbay J, Guercio S, Fearon M, Fonseca K, Hatchette T, Horsman G, Larke B, Li Y, Majury A, Ouellette O, Petric M, Ratnam S, Sevenhuysen C, Van Caeseele P | 2012 | National Collaborating Centre for Infectious Diseases: Evidence Reviews on Pandemic H1N1 | View Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Health care providers | Other |
Les composants sanguins | Clarke G | 2017 | Guide de la pratique transfusionnelle | View Les composants sanguins | Health care providers | Benchmarking and standard setting |
Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis | Chai-Adisaksopha C, Alexander PE, Guyatt G, Crowther MA, Heddle NM, Devereaux PJ, Ellis M, Roxby D, Sessler DI, Eikelboom JW | 2017 | Vox Sang | View Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis | Health care providers | Clinical research |
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Christou G, Iyengar A, Shorr R, Tinmouth A, Saidenberg E, Maze D, Tay J, Bredeson C, Allan DS | 2016 | Transfusion | View Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Health care providers | Clinical research |
Residual Risk of HIV, HCV and HBV in Canada | O'Brien SF, Yi Q-L, Fan W, Scalia V, Goldman M, Fearon MA | 2017 | Transfus Apher Sci | View Residual Risk of HIV, HCV and HBV in Canada | Health care providers | Clinical research |
The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Lagerquist O, Poseluzny D, Werstiuk G, Slomp J, Maier M, Nahirniak S, Clarke G | 2017 | ISBT Sci Ser | View The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Health care providers | Ethical, legal and social implications research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Aphérèse thérapeutique | Pavenski K | 2018 | Guide de la pratique transfusionnelle | View Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Jenkins C | 2019 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Kell System: Anti-Jsa | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Kell System: Anti-Jsa | Health care providers | Benchmarking and standard setting |
Pour un bon équilibre : protection des données dan les travaux de recherche | Ward R | 2019 | Blood.ca website | View Pour un bon équilibre : protection des données dan les travaux de recherche | Health care providers | Other |
Système Lutheran : l’anticorps anti-Lua | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Lutheran : l’anticorps anti-Lua | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Li N, Chiang F, Down DG, Heddle NM | 2021 | Oper Res Health Care | View A decision integration strategy for short-term demand forecasting and ordering for red blood cell components | Health care providers | New or improved product or process |
Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Guide de la pratique transfusionnelle | View Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |